Evidence map›Paper›PMID 36503484›Full record

ArticleBMC cancer2022

Detection and genomic analysis of BRAF fusions in Juvenile Pilocytic Astrocytoma through the combination and integration of multi-omic data.

Melissa Zwaig, Audrey Baguette, Bo Hu, Michael Johnston, Hussein Lakkis, Emily M Nakada, Damien Faury, Nikoleta Juretic, Benjamin Ellezam, Alexandre G Weil and 8 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 1 country.

Melissa ZwaigMcGill Genome Centre and Department of Human Genetics, McGill University, Montreal, Canada.
Audrey BaguetteQuantitative Life Sciences and Lady Davis Institute for Medical Research, Montreal, Quebec, Canada.
Bo HuMcGill Genome Centre and Department of Human Genetics, McGill University, Montreal, Canada.
Michael JohnstonAlberta Children's Hospital Research Institute, Charbonneau Cancer Institute, and Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Hussein LakkisDepartment of Human Genetics and Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Emily M NakadaThe Research Institute of the McGill University Health Centre, Montreal, Canada.
Damien FauryThe Research Institute of the McGill University Health Centre, Montreal, Canada.
Nikoleta JureticThe Research Institute of the McGill University Health Centre, Montreal, Canada.
Benjamin EllezamDepartment of Pathology, Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montréal, QC, H3T 1C5, Canada.
Alexandre G WeilDepartment of Pediatric Neurosurgery, Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montréal, QC, H3T 1C5, Canada.
Jason KaramchandaniDepartment of Pathology, Montreal Neurological Institute, McGill University, Montreal, QC, H3A 2B4, Canada.
Jacek MajewskiMcGill Genome Centre and Department of Human Genetics, McGill University, Montreal, Canada.
Mathieu BlanchetteSchool of Computer Science and McGill Center for Bioinformatics, McGill University, Montréal, Québec, Canada.
Michael D TaylorArthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children Research Institute, Toronto, Canada.
Marco GalloAlberta Children's Hospital Research Institute, Charbonneau Cancer Institute, and Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Claudia L KleinmanDepartment of Human Genetics and Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Nada JabadoDepartment of Human Genetics, Department of Pediatrics, and The Research Institute of the McGill University Health Centre, Montreal, Canada. nada.jabado@mcgill.ca.
Jiannis RagoussisMcGill Genome Centre and Department of Human Genetics, McGill University, Montreal, Canada. ioannis.ragoussis@mcgill.ca.ORCID http://orcid.org/0000-0002-8515-0934
McGill Genome Centre · CAMcGill University Health Centre · CAJewish General Hospital · CACentre Hospitalier Universitaire Sainte-Justine · CAUniversity of Calgary · CAHospital for Sick Children · CAMcGill University · CAMontreal Neurological Institute and Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundJuvenile Pilocytic Astrocytomas (JPAs) are one of the most common pediatric brain tumors, and they are driven by aberrant activation of the mitogen-activated protein kinase (MAPK) signaling pathway. RAF-fusions are the most common genetic alterations identified in JPAs, with the prototypical KIAA1549-BRAF fusion leading to loss of BRAF's auto-inhibitory domain and subsequent constitutive kinase activation. JPAs are highly vascular and show pervasive immune infiltration, which can lead to low tumor cell purity in clinical samples. This can result in gene fusions that are difficult to detect with conventional omics approaches including RNA-Seq.

methodsTo this effect, we applied RNA-Seq as well as linked-read whole-genome sequencing and in situ Hi-C as new approaches to detect and characterize low-frequency gene fusions at the genomic, transcriptomic and spatial level.

resultsIntegration of these datasets allowed the identification and detailed characterization of two novel BRAF fusion partners, PTPRZ1 and TOP2B, in addition to the canonical fusion with partner KIAA1549. Additionally, our Hi-C datasets enabled investigations of 3D genome architecture in JPAs which showed a high level of correlation in 3D compartment annotations between JPAs compared to other pediatric tumors, and high similarity to normal adult astrocytes. We detected interactions between BRAF and its fusion partners exclusively in tumor samples containing BRAF fusions.

conclusionsWe demonstrate the power of integrating multi-omic datasets to identify low frequency fusions and characterize the JPA genome at high resolution. We suggest that linked-reads and Hi-C could be used in clinic for the detection and characterization of JPAs.

Indexed as

AstrocytomaBrain NeoplasmsAdultChildHumansMultiomicsOncogene Proteins, FusionProto-Oncogene Proteins B-rafReceptor-Like Protein Tyrosine Phosphatases, Class 5BRAF protein, humanOncogene Proteins, FusionProto-Oncogene Proteins B-rafPTPRZ1 protein, humanReceptor-Like Protein Tyrosine Phosphatases, Class 5BRAF fusionsHi-CJuvenile Pilocytic AstrocytomaLinked-readsRNA sequencingSingle-cell RNA sequencing

Identifiers

PMID36503484
PMCPMC9743522
OpenAlexW4311125416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.